Rosuvastatin Effect on Serial Echocardiographic Measurement of Coronary Flow Velocity Reserve (RESERVE)

This study is currently recruiting participants.
Verified September 2012 by Asan Medical Center
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Duk-Hyun Kang, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT01490398
First received: December 9, 2011
Last updated: September 20, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2013
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)